↓ Skip to main content

Dove Medical Press

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights

Overview of attention for article published in OncoTargets and therapy, April 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
7 X users

Readers on

mendeley
38 Mendeley
Title
Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
Published in
OncoTargets and therapy, April 2020
DOI 10.2147/ott.s202867
Pubmed ID
Authors

Jason S Starr, Mohamad Bassam Sonbol, Timothy J Hobday, Akash Sharma, Ayse Tuba Kendi, Thorvardur R Halfdanarson

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 13%
Researcher 4 11%
Student > Doctoral Student 4 11%
Other 3 8%
Student > Master 3 8%
Other 8 21%
Unknown 11 29%
Readers by discipline Count As %
Medicine and Dentistry 17 45%
Unspecified 5 13%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Nursing and Health Professions 1 3%
Other 3 8%
Unknown 10 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2020.
All research outputs
#6,415,188
of 25,387,668 outputs
Outputs from OncoTargets and therapy
#312
of 3,016 outputs
Outputs of similar age
#122,869
of 396,814 outputs
Outputs of similar age from OncoTargets and therapy
#11
of 85 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 396,814 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.